- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01745315
Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy
January 29, 2013 updated by: Hakan Aytan, Adana Numune Training and Research Hospital
Comparison of the Use of LigaSure, Halo PKS Cutting Forceps and Enseal Tissue Sealer in Total Laparoscopic Hysterectomy: a Randomised Trial.
There are many instruments with different energy modalities or with different properties that are available for use in total laparoscopic hysterectomy.
The aim of the present study is to compare three of these instruments that are present in our clinic - HALO PKS Cutting Forceps, LigaSure and Enseal Tissue Sealer, in total laparoscopic hysterectomy with respect to operation time, blood loss, change in hemoglobin / hematocrit levels, perioperative complications, return of gastrointestinal activity and hospitalization time.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hakan Aytan, Associate Professor, M.D.
- Phone Number: +905056833866
- Email: drhakanaytan@yahoo.com
Study Locations
-
-
-
Adana, Turkey, 01150
- Adana Numune Training and Research Hospital
-
Contact:
- Hakan Aytan, Associate Professor, M.D.
- Phone Number: +905056833866
- Email: drhakanaytan@yahoo.com
-
Sub-Investigator:
- Hakan Nazik, M.D.
-
Sub-Investigator:
- Raziye Narin, M.D.
-
Sub-Investigator:
- Murat Api, M.D., PhD.
-
Principal Investigator:
- Hakan Aytan, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- any women with the indication of hysterectomy
Exclusion Criteria:
- malignancy
- having 3 or more previous abdominal surgeries
- uterus being larger than 12 weeks of gestation
- patients who must undergo additional surgical procedures during the same operation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: LigaSure (advanced bipolar device)
Laparoscopic hysterectomy will be done with LigaSure in 15 patients.
|
Other Names:
|
Active Comparator: Halo PKSforceps(advanced bipolar device)
Laparoscopic hysterectomy will be done with Halo PKS cutting forceps in 15 patients.
|
Other Names:
|
Active Comparator: EnSeal (advanced bipolar device)
Laparoscopic hysterectomy will be done with EnSeal in 15 patients.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perioperative Outcomes
Time Frame: Until 45 patients are operated (6 months anticipated)
|
Perioperative outcomes will be assessed with respect to complication rates, operation time, blood loss, change in hemoglobin and hemotocrit levels, time to return of gastrointestinal function and hospitalization time.
|
Until 45 patients are operated (6 months anticipated)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hakan Aytan, M.D., Adana Numune Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Anticipated)
June 1, 2013
Study Completion (Anticipated)
June 1, 2013
Study Registration Dates
First Submitted
December 6, 2012
First Submitted That Met QC Criteria
December 7, 2012
First Posted (Estimate)
December 10, 2012
Study Record Updates
Last Update Posted (Estimate)
January 30, 2013
Last Update Submitted That Met QC Criteria
January 29, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- instruments in TLH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perioperative Outcomes
-
Third Military Medical UniversityCompletedPerioperative Outcomes | Oncological OutcomesChina
-
Peking University First HospitalRecruitingProtocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic TherapyPerioperative Care | Antithrombotic Therapy | Perioperative OutcomesChina
-
University of KwaZuluUniversity of Cape Town; African Perioperative Research Group (APORG); Safe Surgery...CompletedSurgery | Perioperative/Postoperative Complications | Perioperative Outcomes | Outcome Assessment | Prospective Studies | Paediatrics | Hospital Mortality | Paediatric Surgery | Developing CountriesSouth Africa, Sudan
-
Konstantinos KouladourosRecruitingPerioperative and Long-term Outcomes of TEM and TEM-ESDGermany
-
Zimmer BiometActive, not recruitingClinical Outcomes | Survivorship | Safety | Functional Outcomes | Radiological OutcomesUnited States
-
Shaukat Khanum Memorial Cancer Hospital & Research...CompletedGastric Cancer, Outcomes, Pakistan, Adjuvant Chemotherapy, Perioperative Chemotherapy
-
ModernaTX, Inc.CompletedPregnancy | Maternal Outcomes | Infant OutcomesUnited States
-
Peking University First HospitalThe Forth Medical Center of PLA General Hospital; Tianjin Orthopedic HospitalRecruitingMalnutrition | Hip Fractures | Elderly Patients | Survival | Perioperative Outcomes | Nutritional InterventionChina
-
University of LiegeCompletedIntraoperative Outcomes | Postoperative Outcomes
-
Teachers College, Columbia UniversityColumbia UniversityNot yet recruitingAdverse Childhood Experiences | Mental Health Outcomes | Perceived School Safety | Educational Outcomes
Clinical Trials on Advanced bipolar devices
-
Severance HospitalCompletedSeroma as Procedural ComplicationKorea, Republic of
-
Swinburne University of TechnologyNational Health and Medical Research Council, Australia; University of British... and other collaboratorsCompletedBipolar Disorder, Currently in RemissionAustralia
-
Federal University of São PauloCompletedRadiation Injuries | TelangiectasisBrazil
-
Konrad E. BlochUniversity of Zurich; Cantonal Hospital of St. Gallen; Kantonsspital Münsterlingen and other collaboratorsCompletedSleep Apnea, ObstructiveSwitzerland
-
Medtronic Surgical TechnologiesCompletedInflammation | Hemorrhage | Arthritis | Osteoarthritis | Surgery | Disability | InfectionUnited Kingdom
-
Selçuk UniversitySuspended
-
Chinese University of Hong KongThe University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... and other collaboratorsCompleted
-
AtriCure, Inc.CompletedAtrial FibrillationUnited States
-
University of CagliariUnknown
-
Fundació Institut de Recerca de l'Hospital de la...CompletedTo Determine the Efficacy of Two Liquid Oxygen DeviceSpain